IFRX
Price
$1.33
Change
+$0.13 (+10.83%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
88.62M
12 days until earnings call
NNVC
Price
$1.36
Change
+$0.03 (+2.26%)
Updated
Apr 24, 04:52 PM (EDT)
Capitalization
21.12M
25 days until earnings call
Ad is loading...

IFRX vs NNVC

Header iconIFRX vs NNVC Comparison
Open Charts IFRX vs NNVCBanner chart's image
InflaRx
Price$1.33
Change+$0.13 (+10.83%)
Volume$400
Capitalization88.62M
NanoViricides
Price$1.36
Change+$0.03 (+2.26%)
Volume$150
Capitalization21.12M
IFRX vs NNVC Comparison Chart
Loading...
IFRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NNVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IFRX vs. NNVC commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IFRX is a Buy and NNVC is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (IFRX: $1.32 vs. NNVC: $1.35)
Brand notoriety: IFRX and NNVC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IFRX: 100% vs. NNVC: 25%
Market capitalization -- IFRX: $88.62M vs. NNVC: $21.12M
IFRX [@Biotechnology] is valued at $88.62M. NNVC’s [@Biotechnology] market capitalization is $21.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IFRX’s FA Score shows that 0 FA rating(s) are green whileNNVC’s FA Score has 0 green FA rating(s).

  • IFRX’s FA Score: 0 green, 5 red.
  • NNVC’s FA Score: 0 green, 5 red.
According to our system of comparison, NNVC is a better buy in the long-term than IFRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IFRX’s TA Score shows that 5 TA indicator(s) are bullish while NNVC’s TA Score has 5 bullish TA indicator(s).

  • IFRX’s TA Score: 5 bullish, 4 bearish.
  • NNVC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both IFRX and NNVC are a good buy in the short-term.

Price Growth

IFRX (@Biotechnology) experienced а +24.53% price change this week, while NNVC (@Biotechnology) price change was +1.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

IFRX is expected to report earnings on Jul 31, 2025.

NNVC is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IFRX($88.6M) has a higher market cap than NNVC($21.1M). NNVC YTD gains are higher at: -5.594 vs. IFRX (-46.559). NNVC has higher annual earnings (EBITDA): -8.59M vs. IFRX (-56.33M). IFRX has more cash in the bank: 57.9M vs. NNVC (3.96M). IFRX has less debt than NNVC: IFRX (898K) vs NNVC (1.5M). IFRX has higher revenues than NNVC: IFRX (168K) vs NNVC (0).
IFRXNNVCIFRX / NNVC
Capitalization88.6M21.1M420%
EBITDA-56.33M-8.59M656%
Gain YTD-46.559-5.594832%
P/E RatioN/AN/A-
Revenue168K0-
Total Cash57.9M3.96M1,463%
Total Debt898K1.5M60%
FUNDAMENTALS RATINGS
IFRX vs NNVC: Fundamental Ratings
IFRX
NNVC
OUTLOOK RATING
1..100
312
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
35
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9595
PRICE GROWTH RATING
1..100
8646
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NNVC's Valuation (35) in the Biotechnology industry is somewhat better than the same rating for IFRX (69). This means that NNVC’s stock grew somewhat faster than IFRX’s over the last 12 months.

NNVC's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as IFRX (100). This means that NNVC’s stock grew similarly to IFRX’s over the last 12 months.

NNVC's SMR Rating (95) in the Biotechnology industry is in the same range as IFRX (95). This means that NNVC’s stock grew similarly to IFRX’s over the last 12 months.

NNVC's Price Growth Rating (46) in the Biotechnology industry is somewhat better than the same rating for IFRX (86). This means that NNVC’s stock grew somewhat faster than IFRX’s over the last 12 months.

NNVC's P/E Growth Rating (100) in the Biotechnology industry is in the same range as IFRX (100). This means that NNVC’s stock grew similarly to IFRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IFRXNNVC
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 9 days ago
77%
Declines
ODDS (%)
Bearish Trend 15 days ago
87%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
View a ticker or compare two or three
Ad is loading...
IFRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NNVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PSNL3.670.26
+7.77%
Personalis
OSUR2.990.03
+1.01%
OraSure Technologies
OCDDY7.550.03
+0.33%
Ocado Group PLC
HDLMY37.31-0.07
-0.19%
HEIDELBERG MATERIALS AG
FJTSF19.61-0.30
-1.49%
Fujitsu Ltd.

IFRX and

Correlation & Price change

A.I.dvisor tells us that IFRX and NNVC have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IFRX and NNVC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IFRX
1D Price
Change %
IFRX100%
+10.00%
NNVC - IFRX
30%
Poorly correlated
+1.23%
TNGX - IFRX
30%
Poorly correlated
-0.68%
VERA - IFRX
28%
Poorly correlated
+5.06%
CRNX - IFRX
28%
Poorly correlated
+3.15%
RNA - IFRX
28%
Poorly correlated
+0.81%
More

NNVC and

Correlation & Price change

A.I.dvisor indicates that over the last year, NNVC has been loosely correlated with MDGL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NNVC jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NNVC
1D Price
Change %
NNVC100%
+1.23%
MDGL - NNVC
34%
Loosely correlated
+3.61%
CYTK - NNVC
31%
Poorly correlated
+6.13%
ZNTL - NNVC
30%
Poorly correlated
+0.67%
IFRX - NNVC
30%
Poorly correlated
+10.00%
AXON - NNVC
29%
Poorly correlated
+2.39%
More